Current medical news and unique business news for anyone who cares about healthcare.
Big pharma takes a lesson in sharing. Pharmaceutical companies trying to make the next big drug don’t seem to be your likely advocates of sharing information. But to save time and money, it looks like sharing in R&D efforts might be the way of the future.
Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) have joined GlaxoSmithKline (NYSE:GSK), Novartis (NYSE:NVR) and others in a public-private partnership, the Structural Genomics Consortium, by pooling cash and scientific resources for research in the three-dimensional structure of proteins. The four Big Pharma companies have pledged a total of $50 million to the operation, and all of its findings are made available to all scientists worldwide.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Autism legislation for research passes. The government’s autism research program will continue after Congress passed a $693 million piece of autism legislation Monday. President Obama is scheduled to sign the bill into law today.
From Blu-rays and Playstations to medical devices… Consumer electronics manufacturer Sony is entering the medical device world with the acquisition of Micronics Inc., a developer of diagnostic products using microfluidic technology.
Decoding operating room noises and feelings. A new online tool helps guide patients through the noises they hear and sensations they feel during invasive procedures. HD Care Compass, launched Thursday, aims to ease the anxiety felt before, during and after surgery.
Genes as a complete network. Four Houston researchers have proposed a unified genetic model in which various genetic diseases and disorders are part of one continuum, as human genome sequencing has unveiled that diseases have gene variants underlying them that make individuals more at risk for other diseases.
